Dr André Schultz is a Respiratory Physician at Princess Margaret Hospital for Children, Clinical Senior Lecturer at the School of Paediatric and Child Health of the University of Western Australia, and Honorary Research Fellow at the Telethon Kids Institute. He is the Director of the Cystic Fibrosis Centre at Princess Margaret Hospital for Children where he leads a multidisciplinary team who cares for over 200 children and young people with cystic fibrosis. He is the Chair of the Child and Adolescent Cystic Fibrosis Consumer Reference Group of Western Australia where patients and families work in partnership with health care professionals and scientist to improve clinical care. He is an emerging scientist who applies science to help children with rare lung disease and their families. Since he completed his doctoral studies in 2010 his research has influenced both national and international clinical guidelines.
He enjoys spending time in the water: swimming, diving or searching for weedy seadragons.
Cystic fibrosis is one of the most common life limiting genetic diseases. It affects multiple organs but mortality is mostly caused progressive lung disease. Life expectancy for cystic fibrosis has increased dramatically over the past few decades. This presentation will briefly cover the main strategies for treatment of cystic fibrosis lung disease before describing new treatments, including the latest disease modifying drugs (CFTR potentiators and correctors) as well as some promising future therapies.